Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT).
The discussions reflect a neutral to slightly positive stance, with mentions of past studies, such as Professor Jean-Yves Reginster’s research, and questions about glucosamine, highlighting an interest in treatment options. The tone is modest, with some users referencing the article and related research but without extensive debate or critique.
AgreementModerate agreement
Most discussions express support or recognition of the study's results, indicating general agreement on its findings.
InterestModerate interest
Posts show moderate curiosity, referencing related treatments like glucosamine and past research, but not deeply exploring implications.
EngagementModerate engagement
Participants briefly discuss the content, such as mentioning the paper or related topics, but do not delve into detailed analysis.
ImpactModerate impact
There is a sense that the publication could influence treatment choices, though the discussions are mainly surface-level and exploratory.
Abstract in brief
Pharmaceutical-grade chondroitin sulfate (CS) at 800mg/day is as effective as celecoxib 200mg/day and more effective than placebo in reducing pain and improving function in patients with symptomatic knee osteoarthritis over a 6-month period.
The study showed significant improvements in pain (measured by VAS) and functional indices (Lequesne Index) for both CS and celecoxib compared to placebo, with no notable difference between the two active treatments.
Both CS and celecoxib had excellent safety profiles, supporting the recommendation of pharmaceutical-grade CS as a first-line treatment option for managing knee osteoarthritis symptoms.]
@adamcifu @chadinabhan Speaking of glucosamine, what do you think of this: https://t.co/vABo9mpz9O.
May 21, 2021 · 1 like · 1,488 followersView post →
O
Osteosyn
@osteosynhealth · X
According to Professor Jean-Yves Reginster’s paper on Annals of the Rheumatic Diseases (2017), Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis https://t.co/TeGPcDIMIS
Nov 5, 2019 · 1 like · 1 share · 157 followersView post →
This meta-analysis evaluates the safety and effectiveness of oral drugs like chondroitin and glucosamine for osteoarthritis treatment, focusing on pain reduction and improved function in knee and hip conditions.
Pharmaceutical-grade chondroitin sulfate at 800mg/day is as effective as celecoxib and superior to placebo in reducing knee osteoarthritis pain and improving function, with a favorable safety profile over six months.
According to Professor Jean-Yves Reginster’s paper on Annals of the Rheumatic Diseases (2017), Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis https://t.co/TeGPcDIMIS
Nov 5, 2019 · 1 like · 1 share · 157 followersView post →
N
Arthritis PDF | PDF | Osteoarthritis | Renal Function